Angie Jiwon Chun’s Post

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/irxNMq #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/RGXB4C #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/8ivlPC #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/GCYI3e #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/icLxaS #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/3YB50x #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/ikKGw9 #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

“Captain T Cell is devoted to developing a new generation of toolbox-engineered T cell-based immunotherapies for solid tumor patients. We have the utmost confidence in the expertise of Charles River as we work to bring our lead candidate to the clinic.” Felix Lorenz, CEO, Captain T Cell Once infused into a patient’s body, these tumor-specific T cells seek to find and destroy tumor cells and may provide an alternative for patients with tumors that no longer respond to other therapies. Read the story in full: https://okt.to/CNVYqk #genemodifiedcelltherapy #genetherapy #tcelltherapy #immunotherapy #viralvectors

Join C-Path's Cure Drug Repurposing Collaboratory team and CURE ID for a groundbreaking Patient-Powered Research Webinar hosted by the Sarcoma Foundation of America, January 18, 1 PM ET. Sarcoma Foundation of America is dedicated to fostering the development of innovative treatment options for those affected by sarcoma. In collaboration with the esteemed CDRC Sarcoma Task Force, we are excited to present a pioneering project that delves into the potential of repurposing existing medications for the benefit of sarcoma patients. This initiative is at the forefront of leveraging real-world data from electronic medical records to invaluable insights shared by patients and their healthcare providers. The goal is to illuminate the path to cost-effective treatments, harnessing the power of existing drugs that, while proven safe, require further evidence to support their novel application in sarcoma therapy. Your involvement is crucial in propelling this research forward, paving the way for new, accessible treatment avenues for the sarcoma community. Learn more and register here: https://lnkd.in/gEBVyzdu. Clear Cell Sarcoma Foundation xCures Memorial Sloan Kettering Cancer Center William Tap Marco Schito Brandi Felser Timothy Stuhlmiller Lennie Woods #CPath #CDRC #CUREID #drugrepurposing #sarcoma #drugdevelopment #datasharing #EHR #collaboration #globalhealth

Millions of patients are diagnosed with cancer each year. The majority of them undergo chemotherapy and/or radiotherapy. Every second patient will experience oral side effects caused by cancer treatment. Because of their impact on the patient’s ability to eat, swallow, breathe…they are the leading cause of treatment dropouts. To learn more how you can help us in our effort to deliver safe, affordable, effective solutions for the treatment of oral side effects contact us at sales@anbiome.com. 🚀 Join us in our endeavor to support cancer patients in their healing journey! #anbiomelifescience #biotech #healthtech #cancersupport #oralhealth #oralmucositis #biotechstartup #biotechsolutions #foodasmedicine #cancersideeffects #cancerpatientsupport #cancerhealing #qualityoflife